| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |